D JEFFREY KEYSER

CIK 1393516 · Chief Operating Officer · last filed 2026-05-14

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$365.9K

Companies

3

Total Filings

15

Lifetime Open-Market Net

$250.0K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
LTRN Director 94,303 $3.88 $365.9K $250.0K 8 2026-05-14
ZS Pharma, Inc. (ZSPH) Delisted Chief Operating Officer 225,323 $0 3 2015-12-11
ENCYSIVE PHARMACEUTICALS INC (ENCY) Delisted V.P., Regulatory Affairs 0 $0 3 2008-04-03

Recent Filings · Page 2 of 2

15 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2015-06-25 ZS Pharma, Inc. (ZSPH) Delisted Grant (A) $0 EDGAR
2014-07-10 ZS Pharma, Inc. (ZSPH) Delisted Grant (A) $0 EDGAR
2008-04-03 ENCYSIVE PHARMACEUTICALS INC (ENCY) Delisted U −109,467 -$257.2K EDGAR
2008-01-15 ENCYSIVE PHARMACEUTICALS INC (ENCY) Delisted Grant (A) +70,000 $0 EDGAR
2007-12-13 ENCYSIVE PHARMACEUTICALS INC (ENCY) Delisted Grant (A) +35,000 $0 EDGAR
Showing 1115 of 15
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.